BeiGene Announces BRUKINSA® (Zanubrutinib) Approved for Treatment of Patients with Mantle Cell Lymphoma in Australia
Marks BRUKINSA’s second approved indication in Australia, on the heels of its recent initial approval in Waldenström’s macroglobulinemia To date,...

Sony kicks off 2026 PlayStation Store Black Friday sale early with up to 75% off games
Democrats Sweep US Midterm Elections, Winning Senate and House as Trump Faces Lame-Duck Presidency
Union Cabinet Approves Two-Year Extension for Agniveer Service Tenure
Kerala Lottery DhanaLekshmi DL-76 results declared for November 4 draw
Kohli’s 74 Seals India’s Auckland Win as DLS Method Decides Series Opener 

















